Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis

Sponsor
Peking University Third Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04953481
Collaborator
(none)
252
1
24
10.5

Study Details

Study Description

Brief Summary

The purpose of this study is to comprehensively investigate and analyze the home care needs and status quo of ALS patients in China, and to clarify their home care needs and status quo, so as to provide reference for the development of home care service planning and policy measures for ALS patients.

Condition or Disease Intervention/Treatment Phase
  • Other: survey

Detailed Description

Amyotrophic lateral sclerosis (ALS) is the most common type of motor neuron disease. It is common in middle-aged and elderly people. Progressive skeletal muscle weakness, atrophy, fascicular fibrillation, bulbar paralysis and pyramidal tract sign are the main clinical manifestations. The survival time is usually 3-5 years. As the pathogenesis of ALS is not fully understood, there is no specific treatment for ALS. The clinical treatment mode of most patients with ALS is hospitalization at the end of the disease and maintenance treatment at home during the disease progression. At present, there are few reports on the home care needs and nursing status of ALS patients in China. This study is a cross-sectional survey. Based on consulting the relevant literature and consulting experts' opinions, the researchers designed the questionnaire of home care needs and nursing status of ALS patients, The convenience sampling method was used to select 126-252 ALS outpatients, 126-252 ALS inpatients, and 126-252 ALS family members from a third class a general hospital in Beijing. The needs and status of home care of ALS patients in China were comprehensively investigated and analyzed, and the needs and status of home care were clarified, so as to provide reference for the development of home care service planning and policy measures for ALS patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
252 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Amyotrophic lateral sclerosis group

Patients with amyotrophic lateral sclerosis undergoing home care.

Other: survey
The general information, home care status and functional status of ALS patients and family caregivers were collected.

Caregiver group

Caregivers

Outcome Measures

Primary Outcome Measures

  1. the Barthel index of ADL [At the time of survey (day 0)]

    the Barthel index of ADL

Secondary Outcome Measures

  1. Caregiver Burden Inventory, CBI [At the time of survey (day 0)]

    Caregiver Burden Inventory, CBI

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
The inclusion criteria of ALS patients:
  1. They met the diagnostic criteria of Chinese guidelines for the diagnosis and treatment of amyotrophic lateral sclerosis; ② Receiving care at home; ③ No cognitive impairment (if the patient is unable to talk and write due to illness, the family members can express it for the patient);

④ Informed consent, willing to participate in this study;

⑤ No mental illness.

The inclusion criteria of caregivers: ① the primary caregiver designated by the patient was responsible for the primary care;

  • They are relatives of patients;

  • No payment for care; ④ Informed consent, willing to participate in this study;

  • No mental illness; ⑥ There was no cognitive impairment.

Exclusion Criteria:
Exclusion criteria of ALS patients:

① severe physical diseases, such as malignant tumor, liver and kidney dysfunction, etc;

② They are participating in other intervention projects.

Exclusion criteria of caregivers:
  • severe physical diseases, such as malignant tumor, liver and kidney dysfunction, etc; ② They are participating in other intervention projects.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University Third Hospital Beijing China

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT04953481
Other Study ID Numbers:
  • M2021023
First Posted:
Jul 8, 2021
Last Update Posted:
Jul 8, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2021